Ameliorative effects of Orlistat and metformin either alone or in combination on liver functions, structure, immunoreactivity and antioxidant enzymes in experimentally induced obesity in male rats

Lopaschuck, 2007, Cardiac energy metabolism in obesity, Circ. Res., 101, 335, 10.1161/CIRCRESAHA.107.150417 Gordon, 1976, Obesity and cardiovascular disease: the framingham study, Clin. Endocrinol. Metabol., 5, 367, 10.1016/S0300-595X(76)80026-6 Björntorp, 1987, Classification of obese patients and complications related to the distribution of surplus fat, Am. J. Clin. Nutr., 47, 1120, 10.1093/ajcn/45.5.1120 Sonmez, 2019, Impact of obesity on the metabolic control of type 2 diabetes: results of the Turkish nationwide survey of glycemic and other metabolic parameters of patients with diabetes mellitus (TEMD obesity study), Obes. Facts, 12, 167, 10.1159/000496624 Bovet, 2017, Health effects of overweight and obesity in 195 countries, N. Engl. J. Med., 377, 1495, 10.1056/NEJMc1710026 Hurren, 2018, Understanding the impact of commonly utilized, non-insulin, glucose-lowering drugs on body weight in patients with type 2 diabetes, Expet Opin. Pharmacother., 19, 1087, 10.1080/14656566.2018.1494727 Lau, 2015, Impact of current and emerging glucose-lowering drugs on body weight in type 2 diabetes, Can. J. Diabetes, 39, S148, 10.1016/j.jcjd.2015.09.090 Domecq, 2015, Clinical review: drugs commonly associated with weight change: a systematic review and meta-analysis, J. Clin. Endocrinol. Metab., 100, 363, 10.1210/jc.2014-3421 Bhan, 2010, Guidelines Oriented Approach in Lipid Lowering (GOALL) Registry and Vascular Protection (VP) Registry Investigators. Relation between obesity and the attainment of optimal blood pressure and lipid targets in high vascular risk outpatients, Am. J. Cardiol., 106, 1270, 10.1016/j.amjcard.2010.06.055 Masmiquel, 2016, Leader 5: prevalence and cardiometabolic impact of obesity in cardiovascular high-risk patients with type 2 diabetes mellitus: baseline global data from the LEADER trial, Cardiovasc. Diabetol., 15, 29, 10.1186/s12933-016-0341-5 Hubert, 1983, Obesity as an independent risk factor for cardiovascular disease: a 26-year follow-up of participants in the Framingham Study, Circulation, 67, 968, 10.1161/01.CIR.67.5.968 Swinburn, 2002, Preventive strategies against weight gain and obesity, Obes. Rev., 3, 289, 10.1046/j.1467-789X.2002.00082.x Kang, 2015, Lifestyle measures in the management of gastro-oesophageal reflux disease: clinical and pathophysiological considerations, Ther Adv Chronic Dis, 6, 51, 10.1177/2040622315569501 Dyson, 2014, Hepatocellular cancer: the impact of obesity, type 2 diabetes and a multidisciplinary team, J. Hepatol., 60, 110, 10.1016/j.jhep.2013.08.011 Memish, 2014, Obesity and associated factors--Kingdom of Saudi Arabia, Prev. Chronic Dis., 9, E174 Abdelrahman, 2021, Metal complex formation and anticancer activity of Cu(I) and Cu(II) complexes with metformin, Molecules, 26, 4730, 10.3390/molecules26164730 Congiu, 2021, Undercover toxic ménage à trois of Amylin, Copper(II) and Metformin in human embryonic kidney cells, Pharmaceutics, 13, 830, 10.3390/pharmaceutics13060830 DeCensi, 2010, Metformin and cancer risk in diabetic patients: a systematic review and meta-analysis, Cancer Prev. Res., 3, 1451, 10.1158/1940-6207.CAPR-10-0157 Chen, 2020, Metformin: current clinical applications in nondiabetic patients with cancer, Aging, 12, 3993, 10.18632/aging.102787 Evans, 2005, Metformin and reduced risk of cancer in diabetic patients, BMJ, 330, 1304, 10.1136/bmj.38415.708634.F7 Y u, 2014, Effect of metformin on cancer risk and treatment outcome of prostate cancer: a meta-analysis of epidemiological observational studies, PLoS One, 9 Aldekhail, 2015, Effect of orlistat on glycaemic control in overweight and obese patients with type 2 diabetes mellitus: a systematic review and meta-analysis of randomized controlled trials, Obes. Rev., 16, 1071, 10.1111/obr.12318 Derosa, 2012, Effects of 1-year orlistat treatment compared to placebo on insulin resistance parameters in patients with type 2 diabetes, J. Clin. Pharm. Therapeut., 37, 187, 10.1111/j.1365-2710.2011.01280.x Avenell, 2004, Systematic review of the long-term effects and economic consequences of treatments for obesity and implications for health improvement, Health Technol. Assess., 8, 1, 10.3310/hta8210 Amin, 2015, Anti-obesity potential of orlistat and amphetamine in rats fed on high fat diet, Middle East Journal of Applied Sciences, 5, 453 Zhang, 2017, Metformin ameliorates diabetic nephropathy in a rat model of low-dose streptozotocin-induced diabetes, Exp. Ther. Med., 14, 383, 10.3892/etm.2017.4475 Carr, 1993, Enzymatic determination of triglyceride, free cholesterol and total cholesterol in tissue lipid extracts, Clin. Chem., 26, 39 Warnick, 1983, Selected methods of clinical chemistry, Amer Assoc Clin Chem, 10, 91 Friedewald, 1982, Estimation of concentration of low-density lipoprotein cholesterol in plasma without use of the preparative ultracentrifuge, Clin. Chem., 18, 499, 10.1093/clinchem/18.6.499 Marklund, 1974, Involvement of the superoxide anion radical in the autoxidation of pyrogallol and a convenient assay for superoxide dismutase, Eur. J. Biochem., 47, 469, 10.1111/j.1432-1033.1974.tb03714.x Ohkawa, 1970, Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction, Anal. Biochem., 95, 351, 10.1016/0003-2697(79)90738-3 Hafeman, 1974, Effect of dietary selenium on erythrocyte and liver glutathione peroxidase in the rat, J. Nulr., 104, 580 Aebi, 1983, Catalase Hu, 1994, Measurement of protein thiol groups and glutathione in plasma, Methods Enzymol., 233, 380, 10.1016/S0076-6879(94)33044-1 Weber, 2015, Determination of protein carbonyls in plasma, cell extracts, tissue homogenates, isolated proteins: focus on sample preparation and derivatization conditions, Redox Biol., 5, 367, 10.1016/j.redox.2015.06.005 Gabe, 1986 Endoh, 2002, Protective effect of a lignan-containing flaxseed extract against CCl4- induced hepatic injury, J. Vet. Med. Sci., 64, 761, 10.1292/jvms.64.761 Collins, 2002, Oxidation of cellular DNA measured with the comet assay, pp147 Dean, 2013 Jain, 2011, Evaluation of efficacy and safety of orlistat in obese patients, Indian Journal of Endocrinology and Metabolism, 15, 99, 10.4103/2230-8210.81938 Broom, 2002, Randomised trial of the effect of orlistat on body weight and cardiovascular disease risk profile in obese patients: UK Multimorbidity Study, Int. J. Clin. Pract., 56, 494, 10.1111/j.1742-1241.2002.tb11307.x Swinburn, 2005, Effect of Orlistat on cardiovascular disease risk in obese adults, Diabetes Obes. Metabol., 7, 254, 10.1111/j.1463-1326.2004.00467.x Othman, 2021, Anti-atherogenic effects of orlistat on obesity-induced vascular oxidative stress rat model, Antioxidants, 10, 251, 10.3390/antiox10020251 Kaya, 2017, The relationship between glycemic variability and inflammatory markers in obese children with insulin resistance and metabolic syndrome, J. Clin. Res. Pediatr. Endocrinol., 9, 202, 10.4274/jcrpe.4031 Othman, 2019, Protective effects of orlistat on lipid profile, cardiac oxidative stress biomarkers and histology in high-fat diet-induced obese rats, IIUM Med. J. Malays., 18, 1 Monguchi, 2017, Excessive intake of trans fatty acid accelerates atherosclerosis through promoting inflammation and oxidative stress in a mouse model of hyperlipidemia, J. Cardiol., 70, 121, 10.1016/j.jjcc.2016.12.012 Pemberton, 2010, In vitro interactions of Extracellular histones with LDL suggest a potential pro-atherogenic role, PLoS One, 5, 10.1371/journal.pone.0009884 Da Silva, 2020, Structured lipid containing behenic acid versus orlistat for weight loss: an experimental study in mice, Pharma Nutrition, 14 Guerciolini, 1997, Mode of action of orlistat, Int. J. Obes. Relat. Metab. Disord. J. Int. Assoc. Study. Obes., 21, S12 Suleiman, 2020, Obesity-induced testicular oxidative stress, inflammation and apoptosis: protective and therapeutic effects of orlistat, Reprod. Toxicol., 95, 113, 10.1016/j.reprotox.2020.05.009 Al-Tahami, 2015, The effects of anti-obesity intervention with orlistat and sibutramine on microvascular endothelial function, Clin. Hemorheol. Microcirc., 59, 323, 10.3233/CH-131765 Steven, 2017, CD40L controls obesity-associated vascular inflammation, oxidative stress, and endothelial dysfunction in high fat diet-treated and db/db mice, Cardiovasc. Res., 114, 312, 10.1093/cvr/cvx197 Guerciolini, 1997, Mode of action of orlistat, Int. J. Obes. Relat. Metab. Disord., 21, S12 Kwon, 2022, The effect of orlistat on sterol metabolism in obese patients, Front. Endocrinol., 13, 10.3389/fendo.2022.824269 Wang, 2021, Dietary sterols and sterol oxidation products on atherosclerosis: an insight provided by liver proteomic and lipidomic, Mol. Nutr. Food Res. Meuwese, 2009, ACAT inhibition and progression of carotid atherosclerosis in patients with familial hypercholesterolemia: the captivate randomized trial, JAMA, 301, 1131, 10.1001/jama.301.11.1131 Simonen, 2002, Body weight modulates cholesterol metabolism in non-insulin dependent type 2 diabetics, Obes. Res., 10, 328, 10.1038/oby.2002.46 Paramsothy, 2011, Plasma sterol evidence for decreased absorption and increased synthesis of cholesterol in insulin resistance and obesity, Am. J. Clin. Nutr., 94, 1182, 10.3945/ajcn.110.006668 Foretz, 2023, Mwtformin : update on mechanisms of action and repurposing potential, Nat. Rev. Endocrinol., 1 Wu, 2017, Metformin reduces the rate of small intestinal glucose absorption in type 2 diabetes, Diabetes Obes. Metabol., 19, 290, 10.1111/dom.12812 Janero, 1990, Malondialdehyde and thiobarbituric acid-reactivity as diagnostic indices of lipid peroxidation and peroxidative tissue injury, Free Radic. Biol. Med., 9, 515, 10.1016/0891-5849(90)90131-2 Ziqubu, 2023, Anti-obesity effects of metformin: a scoping review evaluating the feasibility of Brown adipose tissue as a therapeutic target, Int. J. Mol. Sci., 24, 2227, 10.3390/ijms24032227 Lee, 1998, Metformin decreases food consumption and induces weight loss in subjects with obesity with type II non-insulin-dependent diabetes, Obes. Res., 6, 47, 10.1002/j.1550-8528.1998.tb00314.x Dludla, 2021, Adipokines as a therapeutic target by metformin to improve metabolic function: a systematic review of randomized controlled trials, Pharmacol. Res., 163, 10.1016/j.phrs.2020.105219 Yuan, 2019, Effects of metformin on metabolism of white and brown adipose tissue in obese C57BL/6J mice, Diabetol. Metab. Syndrome, 11, 96, 10.1186/s13098-019-0490-2 Kim, 2016, Metformin prevents fatty liver and improves balance of white/Brown adipose in an obesity mouse model by inducing FGF21, Mediat. Inflamm., 10.1155/2016/5813030 Karise, 2019, Metformin enhances mitochondrial biogenesis and thermogenesis in brown adipocytes of mice, Biomed. Pharmacother., 111, 1156, 10.1016/j.biopha.2019.01.021 Yang, 2017, Metformin, beyond an insulin sensitizer, targeting heart and pancreatic β cells, Biochim. Biophys. Acta, Mol. Basis Dis., 1863, 1984, 10.1016/j.bbadis.2016.09.019 Adeshirlarijaney, 2019, Amelioration of metabolic syndrome by metformin associates with reduced indices of low-grade inflammation independently of the gut microbiota, Am. J. Physiol. Endocrinol. Metab., 317, E1121, 10.1152/ajpendo.00245.2019 Nyambuya, 2020, The impact of metformin and aspirin on T-cell mediated inflammation: a systematic review of in vitro and in vivo findings, Life Sci., 255, 10.1016/j.lfs.2020.117854 LaMoia, 2021, Cellular and molecular mechanisms of metformin action, Endocr. Rev., 42, 77, 10.1210/endrev/bnaa023